Sernova is working on a polymer "cell pouch" system infused with therapeutic islet cells that can administer insulin based on a diabetes patient's blood glucose levels. The device, implanted below the skin in the abdomen using a 15-minute procedure, also will contain the Sertolin local immune protection cell system to prevent transplant rejection.
Cell therapy/device combo for diabetes treatment is in the works
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan